Live Breaking News & Updates on Marketing Authorizations

Stay updated with breaking news from Marketing authorizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acurx Pharmaceuticals (ACXP) Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection

Acurx Pharmaceuticals (ACXP) Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Robertj Deluccia , Trial Oversight Committee , Drug Administration , Data Monitoring Committee , Acurx Pharmaceuticals Inc , Company Scientific Advisory Board , Acurx Pharmaceuticals , Advice Meeting , Modified Intent To Treat , Clinical Cure , Executive Chairman , New Drug Application , Marketing Authorizations , Ibezapolstat Phase , Scientific Advisory Board , Modified Intent , Treat Population , Per Protocol Population , Prescribing Information , Independent Data Monitoring Committee , Fast Track Designated , Gram Positive Selective Spectrum , Qualified Infectious Disease Product , Generating New Antibiotic Incentives Now ,

AstraZeneca says it's withdrawing COVID vaccine amid low demand - National

AstraZeneca says it's withdrawing COVID vaccine amid low demand - National
globalnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalnews.ca Daily Mail and Mail on Sunday newspapers.

Astrazeneca Vaxzevria , David Williams , European Union , Canada National Advisory Committee On Immunization , Global News , Marketing Authorizations , National Advisory Committee ,

Small-cap Shares Fall Sharply - Monday Closing Report

On Monday, 925 stocks advanced, 3039 declined and 118 remained unchanged, with an advance decline ratio of 0.30 on the Bombay Stock Exchange (BSE), indicating negative closing of stocks in broader markets. ....

United States , Kashipur Uttarakhand , Ganesh Benzoplast , Zydus Lifesciences , Bombay Stock Exchange , Adani Green Energy , Gmk Center , Sun Pharmaceutical Industries Inc , Green Hydrogen Derivatives , Authority Of India , Lotus Eye Hospital And Institute , Renewable Energy , Waterways Authority Of India , Battery Energy Storage Systems , Macrotech Developers , Enterpreneurship Foundation Mk Group , Km Of National Waterway , Camlin Fine Sciences , Green Energy , Nifty Media , Nifty Metal , Nifty Microcap , Rajasthan Rajya Vidyut Utpadan Nigam , Renewable Energy Projects , Non Convertible Debentures , Pharmaceutical Industrie ,

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Davidp Luci , Robertj Deluccia , Trial Oversight Committee , Acurx Pharmaceuticals Inc , Data Monitoring Committee , Company Scientific Advisory Board , European Medicines Agency On , Drug Administration , Acurx Pharmaceuticals , New Drug Application , Meeting Request , Meeting Package , Briefing Document , European Medicines Agency , Scientific Advice , Marketing Authorizations , Executive Chairman , Marketing Authorization , Ibezapolstat Phase , Scientific Advisory Board , Clinical Cure , Modified Intent , Treat Population , Per Protocol Population , Prescribing Information ,

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

As previously announced, planning is underway with FDA to advance ibezapolstat into international Phase 3 clinical trials for treatment of C. difficile Infection As anticipated, an End of Phase 2. ....

United States , Davidp Luci , Prnewswire Acurx Pharmaceuticals Inc , Company Scientific Advisory Board , Acurx Pharmaceuticals , European Medicines Agency , Exchange Commission On Form , Society Or Healthcare Epidemiology Of America , Drug Administration , Data Monitoring Committee , Infectious Diseases Society Of America , Acurx Pharmaceuticals Inc , Trial Oversight Committee , Company Ph , Briefing Document , Medium Sized Enterprise , New Drug Application , Meeting Request , Meeting Package , Scientific Advice , Marketing Authorizations , Executive Chairman , Marketing Authorization , Ibezapolstat Phase , Scientific Advisory Board , Clinical Cure ,